Amphastar Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report

Amphastar Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient products. The company’s products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; and lidocaine jelly. Amphastar’s offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Scope

Detailed information on Amphastar Pharmaceuticals Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Amphastar Pharmaceuticals Inc in the form of a SWOT analysis

An in-depth view of the business model of Amphastar Pharmaceuticals Inc including a breakdown and examination of key business segments

News about Amphastar Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Amphastar Pharmaceuticals Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Amphastar Pharmaceuticals Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Amphastar Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Teva Pharmaceutical Industries Ltd

Sandoz Inc

Sagent Pharmaceuticals Inc

Mylan Inc

Galenica AG

Fresenius Kabi USA LLC

Akorn Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Amphastar Pharmaceuticals Inc - Key Facts

Amphastar Pharmaceuticals Inc - Key Employees

Amphastar Pharmaceuticals Inc - Key Employee Biographies

Amphastar Pharmaceuticals Inc - Major Products and Services

Amphastar Pharmaceuticals Inc - History

Amphastar Pharmaceuticals Inc - Company Statement

Amphastar Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Amphastar Pharmaceuticals Inc - Business Description

Business Segment: Active Pharmaceutical Ingredients (API)

Overview

Performance

Business Segment: Finished Pharmaceutical Products

Overview

Performance

Geographical Segment: France

Performance

Geographical Segment: United States

Performance

R&D Overview

Amphastar Pharmaceuticals Inc - Corporate Strategy

Amphastar Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Amphastar Pharmaceuticals Inc - Strengths

Amphastar Pharmaceuticals Inc - Weaknesses

Amphastar Pharmaceuticals Inc - Opportunities

Amphastar Pharmaceuticals Inc - Threats

Amphastar Pharmaceuticals Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Amphastar Pharmaceuticals Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

May 09, 2019: Amphastar Pharmaceuticals reports financial results for the three months ended march 31, 2019d March 31, 2019

Mar 12, 2019: Amphastar Pharmaceuticals announces financial results for the three months and full year ended December 31, 2018

Nov 08, 2018: Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2018

Sep 28, 2018: Amphastar to Expand its Facility in Nanjing, China

Aug 08, 2018: Amphastar Pharmaceuticals reports financial results for the three months ended june 30, 2018

Jul 09, 2018: Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals

May 09, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018

Mar 21, 2018: Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals and Sandoz

Mar 12, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Amphastar Pharmaceuticals Inc, Key Facts

Amphastar Pharmaceuticals Inc, Key Employees

Amphastar Pharmaceuticals Inc, Key Employee Biographies

Amphastar Pharmaceuticals Inc, Major Products and Services

Amphastar Pharmaceuticals Inc, History

Amphastar Pharmaceuticals Inc, Other Locations

Amphastar Pharmaceuticals Inc, Subsidiaries

Amphastar Pharmaceuticals Inc, Key Competitors

Amphastar Pharmaceuticals Inc, Ratios based on current share price

Amphastar Pharmaceuticals Inc, Annual Ratios

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont…1)

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont…2)

Amphastar Pharmaceuticals Inc, Interim Ratios

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Amphastar Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Amphastar Pharmaceuticals Inc, Performance Chart (2014 – 2018)

Amphastar Pharmaceuticals Inc, Ratio Charts

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports